Multiply labs collaborates with industry leaders university of california san francisco, cytiva, thermo fisher scientific and charles river to deliver a successful proof-of-concept of robotic cell therapy manufacturing

San francisco--(business wire)-- #manufacturing--multiply labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs (including but not limited to cell therapies), announced today that its proof-of-concept robotic system, developed along with ucsf, cytiva, thermo fisher scientific and charles river, has been successfully completed. the data from this project indicate that manual cell therapy manufacturing tasks (and in particular, cell expansion processe.
CRL Ratings Summary
CRL Quant Ranking